MedTrace Logo

An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized Trial

NCT00384735 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-10-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact on overall survival of an intensive follow-up protocol (as practiced today at TMH) against a more cost effective follow-up protocol in patients operated for extremity sarcoma.

Conditions

  • Sarcoma

Sponsors & Collaborators

  • Tata Memorial Hospital

    collaborator OTHER_GOV

  • Terry Fox Foundation

    lead OTHER

Principal Investigators

  • Dr. Ajay Puri · Tata Memorial Hospital

Eligibility

Min Age
1 Year
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-01
Primary Completion
2010-06-30
Completion
2015-12-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00384735 on ClinicalTrials.gov